Xiujuan Li Selected Research

Infarction (Infarctions)

4/2022	Inhibition of TRIM14 protects cerebral ischemia/reperfusion injury through regulating NF-κB/NLRP3 pathway-mediated inflammation and apoptosis.
1/2020	Suppressed Vascular Leakage and Myocardial Edema Improve Outcome From Myocardial Infarction.
1/2015	Effects of thrombin and thrombin receptor activation on cardiac function after acute myocardial infarction.
12/2014	Activation of liver X receptor improves viability of adipose-derived mesenchymal stem cells to attenuate myocardial ischemia injury through TLR4/NF-κB and Keap-1/Nrf-2 signaling pathways.
5/2013	NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiujuan Li Research Topics

Disease

22	Neoplasms (Cancer) 02/2022 - 01/2011
9	Hypoxia (Hypoxemia) 08/2021 - 02/2013
8	Inflammation (Inflammations) 03/2018 - 07/2011
7	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2014
5	Infarction (Infarctions) 04/2022 - 05/2013
5	Fibrosis (Cirrhosis) 01/2019 - 12/2014
5	Myocardial Infarction 03/2016 - 03/2014
4	Neoplasm Metastasis (Metastasis) 11/2020 - 01/2011
4	Ischemia 01/2017 - 01/2013
4	Stomach Neoplasms (Stomach Cancer) 05/2016 - 01/2013
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 03/2018
3	Seizures (Absence Seizure) 01/2022 - 11/2019
3	Pain (Aches) 01/2021 - 10/2012
3	Myocardial Ischemia (Ischemic Heart Diseases) 03/2016 - 05/2013
3	Reperfusion Injury 08/2014 - 05/2013
2	Infections 04/2022 - 05/2013
2	Encephalitis (Encephalitis, Rasmussen) 04/2022 - 01/2022
2	Pre-Eclampsia (Preeclampsia) 02/2022 - 01/2021
2	Ovarian Neoplasms (Ovarian Cancer) 02/2022 - 01/2022
2	Glioma (Gliomas) 01/2022 - 12/2015
2	Gestational Diabetes (Gestational Diabetes Mellitus) 07/2021 - 01/2015
2	Melanoma (Melanoma, Malignant) 11/2020 - 01/2019
2	Atherosclerotic Plaque (Atheroma) 08/2020 - 01/2016
2	Body Weight (Weight, Body) 12/2018 - 09/2014
2	Myeloid Leukemia (Leukemia, Myelocytic) 04/2018 - 10/2017
2	Diabetic Cardiomyopathies 01/2017 - 03/2016
2	Lung Neoplasms (Lung Cancer) 10/2014 - 11/2013
1	Leukocytosis (Pleocytosis) 04/2022
1	Neurologic Manifestations (Neurological Manifestations) 04/2022
1	Brain Ischemia (Cerebral Ischemia) 04/2022
1	Bone Resorption 01/2022
1	Periapical Periodontitis (Apical Periodontitis) 01/2022
1	Epileptic Syndromes 01/2022
1	Drug Resistant Epilepsy 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Viral Encephalitis 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2022
1	Myopia 11/2021
1	Refractive Errors (Refractive Error) 11/2021
1	Thrombosis (Thrombus) 08/2021

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 04/2022 - 10/2012
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 07/2011
6	Pharmaceutical PreparationsIBA 01/2021 - 11/2013
5	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
5	CytokinesIBA 01/2019 - 12/2014
4	Biological ProductsIBA 02/2022 - 05/2013
3	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2020
3	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 11/2013
2	Myelin-Oligodendrocyte GlycoproteinIBA 04/2022 - 01/2021
2	AutoantibodiesIBA 01/2022 - 01/2021
2	Circular RNAIBA 01/2022 - 11/2020
2	Oxygen (Dioxygen)IBA 08/2021 - 05/2013
2	CholesterolIBA 07/2021 - 01/2016
2	Insulin (Novolin)FDA Link 07/2021 - 05/2013
2	IgA receptor (protein B)IBA 11/2020 - 10/2017
2	CSK Tyrosine-Protein KinaseIBA 01/2020 - 07/2012
2	Interleukin-6 (Interleukin 6)IBA 04/2018 - 12/2014
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2017 - 01/2015
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2017 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 01/2013
2	Sirtuin 1IBA 01/2017 - 03/2016
2	ResveratrolIBA 01/2017 - 08/2014
2	C-Reactive ProteinIBA 01/2016 - 09/2009
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2015 - 07/2012
2	Heroin (Diamorphine)IBA 04/2015 - 01/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2014 - 07/2012
2	MicroRNAs (MicroRNA)IBA 11/2014 - 01/2013
1	triphenyltetrazoliumIBA 04/2022
1	Sincalide FDA Link 02/2022
1	CateninsIBA 02/2022
1	Cadherins (E-Cadherin)IBA 02/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	ImmunosorbentsIBA 01/2022
1	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 01/2022
1	AntibodiesIBA 01/2022
1	EnzymesIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	CEP 33779IBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	Atropine FDA LinkGeneric 11/2021
1	Adenosine Monophosphate (AMP)IBA 11/2021
1	Hemoglobins (Hemoglobin)IBA 08/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2021
1	LipidsIBA 08/2021
1	Ketone BodiesIBA 08/2021
1	ZincIBA 07/2021
1	LDL CholesterolIBA 07/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 04/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021

Therapy/Procedure

17	Therapeutics 02/2022 - 04/2011
4	Drug Therapy (Chemotherapy) 05/2016 - 01/2011
2	Immunotherapy 01/2022 - 01/2022
2	Length of Stay 02/2016 - 04/2015
2	Aftercare (After-Treatment) 01/2016 - 04/2015
1	Ketogenic Diet 01/2022